Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four
- PMID: 17628448
- DOI: 10.1016/j.mod.2007.05.004
Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four
Abstract
Absence of the fibronectin (FN) gene leads to early embryonic lethality in both 129S4 and C57BL/6J strains due to severe cardiovascular defects. However, heart development is arrested at different stages in these embryos depending on the genetic background. In the majority of 129S4 FN-null embryos, heart progenitors remain at their anterior bilateral positions and fail to fuse at the midline to form a heart tube. However, on the C57BL/6J genetic background, cardiac development progresses further and results in a centrally positioned and looped heart. To find factor(s) involved in embryonic heart formation and governing the extent of heart development in FN-null embryos in 129S4 and C57BL/6J strains, we performed genetic mapping and haplotype analyses. These analyses lead to identification of a significant linkage to a 1-Mbp interval on chromosome four. Microarray analysis and sequencing identified 21 genes in this region, including five that are differentially expressed between the strains, as potential modifiers. Since none of these genes was previously known to play a role in heart development, one or more of them is likely to be a novel modifier affecting cardiac development. Identification of the modifier would significantly enhance our understanding of the molecular underpinning of heart development and disease.
Similar articles
-
Overlapping and independent functions of fibronectin receptor integrins in early mesodermal development.Dev Biol. 1999 Nov 15;215(2):264-77. doi: 10.1006/dbio.1999.9451. Dev Biol. 1999. PMID: 10545236
-
Confirmation of provisional quantitative trait loci for voluntary alcohol consumption: genetic analysis in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors.Pharmacogenet Genomics. 2008 Dec;18(12):1071-82. doi: 10.1097/FPC.0b013e32831367f0. Pharmacogenet Genomics. 2008. PMID: 19008751
-
Identification of novel modifier loci of Apc Min affecting mammary tumor development.Cancer Res. 2007 Dec 1;67(23):11226-33. doi: 10.1158/0008-5472.CAN-07-2487. Cancer Res. 2007. PMID: 18056448
-
Strain-specific modifier genes of Cecr2-associated exencephaly in mice: genetic analysis and identification of differentially expressed candidate genes.Physiol Genomics. 2012 Jan 18;44(1):35-46. doi: 10.1152/physiolgenomics.00124.2011. Epub 2011 Nov 1. Physiol Genomics. 2012. PMID: 22045912
-
Genetic mechanisms controlling cardiovascular development.Ann N Y Acad Sci. 2008 Mar;1123:10-9. doi: 10.1196/annals.1420.003. Ann N Y Acad Sci. 2008. PMID: 18375573 Review.
Cited by
-
Fibronectins in vascular morphogenesis.Angiogenesis. 2009;12(2):165-75. doi: 10.1007/s10456-009-9136-6. Epub 2009 Feb 14. Angiogenesis. 2009. PMID: 19219555 Free PMC article. Review.
-
Extracellular matrix-based biomaterials for cardiac regeneration and repair.Heart Fail Rev. 2021 Sep;26(5):1231-1248. doi: 10.1007/s10741-020-09953-9. Heart Fail Rev. 2021. PMID: 32306220 Review.
-
Particulate Matter 2.5 Induced Developmental Cardiotoxicity in Chicken Embryo and Hatchling.Front Pharmacol. 2020 Jun 5;11:841. doi: 10.3389/fphar.2020.00841. eCollection 2020. Front Pharmacol. 2020. PMID: 32581800 Free PMC article.
-
Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in vivo in mice.Dis Model Mech. 2014 Sep;7(9):1057-68. doi: 10.1242/dmm.016535. Epub 2014 Jul 25. Dis Model Mech. 2014. PMID: 25062689 Free PMC article.
-
Role for p21-activated kinase PAK4 in development of the mammalian heart.Transgenic Res. 2012 Aug;21(4):797-811. doi: 10.1007/s11248-011-9578-7. Epub 2011 Dec 16. Transgenic Res. 2012. PMID: 22173944
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous